UA39975C2 - Вакцина проти респіраторно-репродуктивного синдрому свиней - Google Patents

Вакцина проти респіраторно-репродуктивного синдрому свиней

Info

Publication number
UA39975C2
UA39975C2 UA96103815A UA96103815A UA39975C2 UA 39975 C2 UA39975 C2 UA 39975C2 UA 96103815 A UA96103815 A UA 96103815A UA 96103815 A UA96103815 A UA 96103815A UA 39975 C2 UA39975 C2 UA 39975C2
Authority
UA
Ukraine
Prior art keywords
swine
vaccine against
against respiratory
reproductive syndrome
diseases
Prior art date
Application number
UA96103815A
Other languages
English (en)
Inventor
Ернст Хайнен
Норберт Шмеєр
Вернер Хербст
Original Assignee
Баєр Акціенгезельшафт
Байер Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Баєр Акціенгезельшафт, Байер Акциенгезельшафт filed Critical Баєр Акціенгезельшафт
Publication of UA39975C2 publication Critical patent/UA39975C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electronic Switches (AREA)

Abstract

Винахід стосується сфери медицини, а саме - перетворення енергії зовнішнього джерела в електронну енергію заданого рівня при проходженні через трансформатор, перетворювач, комутатор та активні елементи, що дає можливість лікування захворювань дією електричного струму на кров і може бути використаний для лікування всіх захворювань організму.
UA96103815A 1994-03-07 1995-02-22 Вакцина проти респіраторно-репродуктивного синдрому свиней UA39975C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4407489A DE4407489A1 (de) 1994-03-07 1994-03-07 Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines
PCT/EP1995/000642 WO1995024214A1 (de) 1994-03-07 1995-02-22 Vakzine zur prävention von respirations- und reproduktionserkrankungen des schweines, die parainfluenzaviren enthält

Publications (1)

Publication Number Publication Date
UA39975C2 true UA39975C2 (uk) 2001-07-16

Family

ID=6512034

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96103815A UA39975C2 (uk) 1994-03-07 1995-02-22 Вакцина проти респіраторно-репродуктивного синдрому свиней

Country Status (19)

Country Link
US (1) US5910310A (uk)
EP (1) EP0804232A1 (uk)
JP (1) JPH09509949A (uk)
CN (1) CN1147769A (uk)
AU (1) AU700160B2 (uk)
BR (1) BR9507012A (uk)
CA (1) CA2184833A1 (uk)
CZ (1) CZ261796A3 (uk)
DE (1) DE4407489A1 (uk)
HR (1) HRP950088A2 (uk)
HU (1) HU219884B (uk)
MX (1) MX9603896A (uk)
NZ (1) NZ281615A (uk)
PL (1) PL316178A1 (uk)
RU (1) RU2162710C2 (uk)
SK (1) SK113996A3 (uk)
UA (1) UA39975C2 (uk)
WO (1) WO1995024214A1 (uk)
ZA (1) ZA951831B (uk)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27788C2 (uk) * 1991-06-06 2000-10-16 Стіхтінг Сентрал Діргенескюндіг Інстітют Композиція, що містить виділений фактор лелістада, вакцинна композиція для вакцинації тварин (варіанти), діагностичний набір для виявлення антитіла
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US6380376B1 (en) * 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6773908B1 (en) 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2366072C (en) * 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
CA2650236C (en) * 1999-04-22 2016-01-12 United States Of America, As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
EP1300465A1 (de) * 2001-10-08 2003-04-09 Agrobiogen GmbH Biotechnologie Verfahren und Vorrichtung zur Isolierung von RNS-Proben
CA2743750A1 (en) * 2002-02-21 2003-09-04 Medimmune, Llc Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus
US8034773B2 (en) * 2004-02-05 2011-10-11 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
AU2005232541A1 (en) * 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine
JP2008503727A (ja) * 2004-06-18 2008-02-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ウイルス感染した生物およびワクチン接種した生物の同定
JP2008505878A (ja) * 2004-07-08 2008-02-28 エイムスコ・リミテッド 医薬
US7632636B2 (en) * 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
US8178649B2 (en) * 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
PT2369001T (pt) 2005-06-24 2016-10-25 Univ Minnesota Vírus srrp, clones infecciosos, os seus mutantes e processos de utilização
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
BRPI0917887A2 (pt) * 2008-08-25 2019-09-03 Boehringer Ingelheim Vetmedica Inc vacina contra síndrome reprodutiva e respiratória suína altamente patogênica (hp pprs)
AR078253A1 (es) * 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
MY186535A (en) 2011-02-17 2021-07-26 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain
MY183980A (en) 2011-02-17 2021-03-17 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
US9315781B2 (en) 2011-07-29 2016-04-19 Boehringer Ingelheim Vetmedica Gmbh Infectious CDNA clone of european PRRS virus and uses thereof
WO2014150822A2 (en) 2013-03-15 2014-09-25 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
CA3010227A1 (en) * 2016-01-04 2017-07-13 Kansas State University Research Foundation Porcine parainfluenza virus compositions and related methods
CN108018261B (zh) * 2016-11-02 2021-04-27 普莱柯生物工程股份有限公司 犬副流感病毒毒株及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215107A (en) * 1978-12-29 1980-07-29 Merck & Co., Inc. Parainfluenza virus vaccine and its preparation
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
NZ230425A (en) * 1988-09-02 1992-07-28 Molecular Eng Ass Production of paramyxovirus fusion (f) protein using recombinant baculovirus expression vector
ES2083764T5 (es) * 1991-10-14 2009-04-01 Intervet International Bv Vacuna para el sindrome respiratorio reproductivo porcino (srrp) y diagnostico.

Also Published As

Publication number Publication date
HRP950088A2 (en) 1997-08-31
EP0804232A1 (de) 1997-11-05
AU1758995A (en) 1995-09-25
HUT74824A (en) 1997-02-28
RU2162710C2 (ru) 2001-02-10
PL316178A1 (en) 1996-12-23
CN1147769A (zh) 1997-04-16
WO1995024214A1 (de) 1995-09-14
MX9603896A (es) 1997-03-29
CA2184833A1 (en) 1995-09-14
HU219884B (hu) 2001-08-28
DE4407489A1 (de) 1995-09-14
ZA951831B (en) 1995-12-12
CZ261796A3 (en) 1997-02-12
BR9507012A (pt) 1997-09-16
NZ281615A (en) 1997-11-24
AU700160B2 (en) 1998-12-24
JPH09509949A (ja) 1997-10-07
SK113996A3 (en) 1997-04-09
US5910310A (en) 1999-06-08
HU9602421D0 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
UA39975C2 (uk) Вакцина проти респіраторно-репродуктивного синдрому свиней
UA39955C2 (uk) Спосіб піддатливого утримання навантаження і кріплення, яке використовується при його здійсненні
ES2156150T3 (es) Combinacion terapeutica que contiene interferon.
EA200100721A1 (ru) Производное габапентина для предупреждения и лечения висцеральной боли
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
NL190832C (nl) Tandbehandelingsmiddel met anti-tandsteenwerking.
BR0107705A (pt) Uso de uma alìquota de sangue modificado em um paciente para tratamento de falência cardìaca congestiva
DK184286A (da) Bestraalingssteriliseret, emballeret medicinsk indretning
SG17493G (en) Ozone decontamination of blood and blood products
WO2003095018A3 (en) Electrical stimulation unit and waterbath system
DK0610368T3 (da) Behandling af acne eller pseudofolliculitis barbae
SE9701161D0 (sv) New use I
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
UA39968C2 (uk) Спосіб одержання очищеної ортофосфорної кислоти
ITMI913493A0 (it) Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
EA200400535A1 (ru) ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
NZ515173A (en) Treatment of hypersensitivity reaction disorders
DE59508725D1 (de) Arztlicher, insbesondere zahnärztlicher Behandlungsstuhl
DE69803303D1 (de) Verwendung von endipalen zur behandlung von schuppenflechte
RU93007819A (ru) Способ лечения больных с заболеваниями цнс и устройство для осуществления способа
KR950010921A (ko) 저주파 전기치료기
ATE209941T1 (de) Arzneigeräte für die behandlung von blutgefässen mittels ionisierungsbestrahlung
RU95104172A (ru) Устройство для лечения больных энурезом